Ocular Therapeutix, Inc (NASDAQ:OCUL) has 242 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 5,045,557 | 47.79% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | -29 | 0.00% | $0.00 |
| SUMMER ROAD LLC | 31 Dec, 2025 | 0 | -1,471,102 | -11.69% | $0.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 0 | 11,305,554 | 110.30% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 2,411,953 | 26.32% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -65,490 | -7.09% | $0.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Dec, 2025 | 0 | 620,700 | 15.50% | $0.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 0 | -3,861,723 | -32.36% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 5,144 | 0.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 1,018,094 | 30.50% | $0.00 |
| VR Adviser, LLC | 31 Dec, 2025 | 0 | -5,845,915 | -44.42% | $0.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Dec, 2025 | 0 | 917,512 | 26.79% | $0.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 0 | -377,001 | -6.16% | $0.00 |
| Janus Henderson Group Plc | 31 Dec, 2025 | 0 | 2,180,702 | 106.45% | $0.00 |
| Logos Global Management LP | 31 Dec, 2025 | 0 | 250,000 | 7.69% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 736,318 | 21.28% | $0.00 |
| Paradigm Biocapital Advisors LP | 31 Dec, 2025 | 0 | -562,023 | -16.07% | $0.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 0 | -647,825 | -16.80% | $0.00 |
| Octagon Capital Advisors LP | 31 Dec, 2025 | 0 | -400 | -0.02% | $0.00 |
| DELTEC ASSET MANAGEMENT LLC | 31 Dec, 2025 | 0 | -274,525 | -9.94% | $0.00 |